New prostate surgery aims to cut incontinence by saving the urethra

NCT ID NCT07678489

Recruiting now Disease control Sponsor: Sami-Ramzi Leyh-Bannurah Source: ClinicalTrials.gov ↗

First seen Jul 01, 2026 · Last updated Jul 02, 2026 · Updated 1 time

Summary

This study tests a new robot-assisted surgery for localized prostate cancer that leaves the full length of the urethra intact. The goal is to help men regain urinary continence faster after prostate removal. About 60 men with early-stage prostate cancer will undergo the procedure to see if it is safe and feasible.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Total en bloc urethra preservation at robot-assisted prostatectomy (ToP-RAP)
What this could lead to: If successful, this technique could help men recover bladder control faster after prostate cancer surgery, improving quality of life.
What could go wrong: This is a small, early feasibility study. The technique may not work for all patients, and there is a risk of cancer not being fully removed.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for LOCALIZED PROSTATE CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

prostate cancer prostate carcinoma Urinary Incontinence

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

PROSTATE CANCER (LOCALIZED), URINARY INCONTINENCE (C61)

Contacts and locations

Show contact details

Locations

Clinic Bel Etage
RECRUITING

Düsseldorf, 40217, Germany

Contact Email: •••••@•••••
Diakonie Klinikum Jung-Stilling
RECRUITING

Siegen, 57074, Germany

More trials for these conditions

Other studies related to the condition(s) this trial covers.